InflaRx NV IFRX

NAS: IFRX | ISIN: NL0012661870 14/11/2024

2,030 USD (+18,71%)

(+18,71%) 14/11/2024

Grafiek InflaRx NV

Grafiek InflaRx NV

1 dag1d 18,71%
1 week1w 30,13%
1 maand1m 37,16%
3 maanden3m 50,37%
6 maanden6m 45,00%
1 jaar1j 40,00%
5 jaar5j -12,50%

InflaRx NV in het nieuws

Toon enkel gratis nieuws

3 maart 2021 · InflaRx to Present at Upcoming Investor Conferences · Persbericht

1 maart 2021 · InflaRx Announces Closing of $75 Million Public Offering of Common Shares and One-Year Warrants · Persbericht

24 februari 2021 · InflaRx Announces Proposed Offering of Common Shares and One-Year Warrants · Persbericht

11 februari 2021 · InflaRx Announces Presentation of New C5a and Vilobelimab (IFX-1) Data from Phase IIB SHINE Study at the 2021 Virtual European Hidradenitis Suppurativa Foundation Conference · Persbericht

11 januari 2021 · InflaRx Provides Update on Vilobelimab (IFX-1) Development · Persbericht

7 januari 2021 · InflaRx to Present at Upcoming Annual J.P. Morgan Healthcare Conference · Persbericht

5 januari 2021 · InflaRx Completes Enrollment in Vilobelimab (IFX-1) European Phase II Study in ANCA-associated Vasculitis · Persbericht

Profiel InflaRx NV

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.inflarx.de

Hoofdzetel: Jena Duitsland

Werknemers: 21

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe